Qiang Tong Selected Research

Sirtuins

1/2017	Correction: The mechanism of sirtuin 2-mediated exacerbation of alpha-synuclein toxicity in models of Parkinson disease.
1/2017	The mechanism of sirtuin 2-mediated exacerbation of alpha-synuclein toxicity in models of Parkinson disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Qiang Tong Research Topics

Disease

26	Neoplasms (Cancer) 04/2024 - 11/2005
14	Stomach Neoplasms (Stomach Cancer) 08/2023 - 01/2010
8	Parkinson Disease (Parkinson's Disease) 04/2021 - 01/2016
8	Carcinoma (Carcinomatosis) 02/2011 - 11/2003
7	Neoplasm Metastasis (Metastasis) 04/2024 - 05/2008
7	Reperfusion Injury 01/2021 - 02/2015
5	Body Weight (Weight, Body) 12/2022 - 10/2018
5	Inflammation (Inflammations) 05/2022 - 01/2015
5	Type 2 Diabetes Mellitus (MODY) 10/2021 - 09/2013
5	Myocardial Infarction 01/2019 - 01/2017
4	Esophageal Neoplasms (Esophageal Cancer) 04/2024 - 02/2011
4	Ankylosing Spondylitis 02/2023 - 10/2012
4	Obesity 10/2021 - 12/2011
4	Myocardial Ischemia (Ischemic Heart Diseases) 01/2019 - 01/2017
4	Prostatic Neoplasms (Prostate Cancer) 01/2018 - 03/2015
3	Esophageal Squamous Cell Carcinoma 04/2024 - 01/2018
3	Glioma (Gliomas) 04/2024 - 08/2015
3	Breast Neoplasms (Breast Cancer) 04/2024 - 02/2009
3	COVID-19 02/2024 - 01/2020
3	Insulin Resistance 04/2022 - 12/2011
2	Carcinogenesis 04/2024 - 05/2008
2	Infections 02/2024 - 01/2020
2	Psoriatic Arthritis 11/2023 - 02/2023
2	Overweight 12/2022 - 10/2021
2	Pneumonia (Pneumonitis) 05/2021 - 01/2015
2	Anastomotic Leak 01/2021 - 01/2020
2	Ischemia 01/2021 - 02/2015
2	Shock 01/2020 - 01/2020
2	Infarction (Infarctions) 01/2019 - 01/2017
2	Ischemic Stroke 01/2019 - 01/2017
2	Colorectal Neoplasms (Colorectal Cancer) 01/2019 - 01/2006
2	Hepatocellular Carcinoma (Hepatoma) 01/2018 - 10/2005
2	Brain Ischemia (Cerebral Ischemia) 01/2017 - 10/2008
2	Catalepsy 04/2016 - 01/2016

Drug/Important Bio-Agent (IBA)

15	Proteins (Proteins, Gene)FDA Link 04/2024 - 11/2003
5	EnzymesIBA 04/2024 - 02/2009
5	Sirtuin 3IBA 05/2022 - 01/2020
5	Biomarkers (Surrogate Marker)IBA 01/2022 - 04/2016
5	AntioxidantsIBA 01/2019 - 04/2016
4	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2024 - 02/2015
4	CytokinesIBA 12/2023 - 06/2012
4	Carrier Proteins (Binding Protein)IBA 04/2023 - 10/2010
4	Indicators and Reagents (Reagents)IBA 02/2023 - 10/2010
4	manganese tetrakis-(N-ethyl-2 pyridyl) porphyrinIBA 01/2020 - 01/2016
4	Neuroprotective AgentsIBA 01/2019 - 01/2016
4	SurvivinIBA 02/2011 - 11/2005
3	Fluorouracil (Carac)FDA LinkGeneric 08/2023 - 06/2016
3	Glucose (Dextrose)FDA LinkGeneric 04/2022 - 01/2021
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 01/2014
3	Antineoplastic Agents (Antineoplastics)IBA 01/2019 - 12/2016
3	ManganeseIBA 01/2019 - 06/2016
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2015 - 04/2013
3	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 02/2011 - 10/2005
2	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 04/2023 - 07/2012
2	AlbuminsIBA 02/2023 - 10/2021
2	Phenobarbital (Luminal)FDA Link 01/2023 - 10/2016
2	Therapeutic UsesIBA 10/2022 - 08/2015
2	LipidsIBA 10/2021 - 01/2018
2	InflammasomesIBA 04/2021 - 01/2019
2	Leucine-Rich Repeat ProteinsIBA 04/2021 - 01/2019
2	NucleotidesIBA 04/2021 - 01/2019
2	buyang huanwuIBA 01/2021 - 01/2019
2	Hypoglycemic Agents (Hypoglycemics)IBA 06/2019 - 04/2016
2	Thioctic Acid (Lipoic Acid)IBA 01/2019 - 04/2016
2	GW 501516IBA 01/2019 - 01/2016
2	Small Interfering RNA (siRNA)IBA 01/2019 - 01/2014
2	Sulfhydryl Compounds (Thiols)IBA 01/2019 - 12/2016
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2019 - 01/2016
2	PorphyrinsIBA 01/2018 - 06/2016
2	schizandrin BIBA 01/2017 - 08/2015
2	SirtuinsIBA 01/2017 - 01/2017
2	SynucleinsIBA 01/2017 - 04/2016
2	Sirtuin 2IBA 01/2017 - 03/2013
2	alpha-SynucleinIBA 01/2017 - 01/2017
2	Plasminogen Activator Inhibitor 1IBA 12/2016 - 01/2016
2	RotenoneIBA 04/2016 - 01/2016
2	Liposomes (Liposome)IBA 01/2014 - 02/2009
2	Transcription Factors (Transcription Factor)IBA 01/2014 - 06/2012
2	Gemcitabine FDA Link 04/2011 - 02/2009
2	N- (2- cyclohexyloxy- 4- nitrophenyl)methanesulfonamideIBA 02/2011 - 05/2008
2	Messenger RNA (mRNA)IBA 10/2010 - 01/2006
2	Telomerase (Telomerase Reverse Transcriptase)IBA 11/2009 - 12/2008
2	DNA (Deoxyribonucleic Acid)IBA 01/2009 - 11/2003
2	benzyloxycarbonylleucyl-leucyl-leucine aldehydeIBA 12/2008 - 10/2004
2	UbiquitinIBA 12/2008 - 10/2004
1	Peroxidase (Myeloperoxidase)IBA 04/2024
1	Oxidoreductases (Dehydrogenase)IBA 04/2024
1	CatalaseIBA 04/2024
1	BromidesIBA 04/2024
1	IonsIBA 04/2024
1	Glutathione (Reduced Glutathione)IBA 04/2024
1	Propidium (Propidium Iodide)IBA 04/2024

Therapy/Procedure

16	Therapeutics 10/2023 - 10/2004
9	Drug Therapy (Chemotherapy) 08/2023 - 04/2011
5	Radiotherapy 01/2018 - 02/2011
2	Immunotherapy 04/2024 - 01/2022
2	Fecal Microbiota Transplantation 08/2020 - 06/2019
2	Chinese Traditional Medicine (Traditional Chinese Medicine) 04/2019 - 01/2019
2	Transplantation 09/2013 - 11/2005
1	Photothermal Therapy 04/2024